1. Recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC): What about second-line chemotherapy combining cetuximab and platinum-doublet after EXTREME protocol?. (February 2017) Authors: Regnier-Gavier, O.; Coliat, P.; Carinato, H.; Burgy, M.; Exinger, D.; Fischbach, C.; Kalish-Weindling, M.; Ferry, R.; Flesch, H.; Bronner, G.; Hemar, P.; Schultz, P.; Prebay, D.; Borel, C. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Retrospective analysis of bevacizumab use in combination with irinotecan for recurrent glioblastoma: a single-institution experience. (February 2017) Authors: Besson, C.; Waissi, W.; Velten, M.; Nguyen Them, L.; Schott, R.; Prebay, D.; Etienne-Selloum, N. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗